C91.10 — Chronic lymphocytic leukemia of B-cell type not having achieved remissionICD-10-CM
No Prior Auth Required
Code is covered without prior authorization (high confidence)
A59004 — Billing and Coding: MolDX: Minimal Residual Disease Testing for Hematologic Cancers
J05
A57554 — Billing and Coding: Immune Globulins
J05
L38835 — MolDX: Minimal Residual Disease Testing for Cancer
J05
L34771 — Immune Globulins
J05
L35000
Ask Verity about documentation requirements, denial risks, or coverage in your state.
J06
L39189 — Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG)
J06
L36850 — Peripheral Nerve Blocks
J06
A59101 — Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J06
L39297 — Off-label Use of Rituximab and Rituximab Biosimilars
J06
A59105 — Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
A60186 — Billing and Coding: Off-label Use of Rituximab and Rituximab Biosimilars
J06
L39314 — Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
A57452 — Billing and Coding: Peripheral Nerve Blocks
J06
A60187 — Billing and Coding: Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
A58921 — Billing and Coding: Mass Spectrometry (MS) Testing in Monoclonal Gammopathy (MG)
J06
A59926 — Billing and Coding: Molecular Pathology Procedures
J06
L40181 — Off-Label Use of Intravenous Immune Globulin (IVIG)
J06
A56199 — Billing and Coding: Molecular Pathology Procedures
J06
L40180 — Off-label Use of Rituximab and Rituximab Biosimilars
J06
A57778 — Billing and Coding: Immune Globulin
J09